Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

129 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Emerging Immunotargets in Bladder Cancer.
Massari F, Ciccarese C, Vau N, Santoni M, Montironi R, Cheng L, Marques RC, Scarpelli M, Fonseca J, Matrana MR, Holger M, Cascinu S, Tortora G, Lopez-Beltran A. Massari F, et al. Among authors: ciccarese c. Curr Drug Targets. 2016;17(7):757-70. doi: 10.2174/1389450117666160201105537. Curr Drug Targets. 2016. PMID: 26844572
2023 ASCO genitourinary cancers symposium: focus on renal cell carcinoma.
Anghelone A, Strusi A, Scala A, Panebianco M, Ciccarese C, Iacovelli R. Anghelone A, et al. Among authors: ciccarese c. Expert Rev Anticancer Ther. 2023 Jul;23(7):669-672. doi: 10.1080/14737140.2023.2218091. Epub 2023 May 29. Expert Rev Anticancer Ther. 2023. PMID: 37246571
Adenocarcinoma of the paraurethral glands: a case report.
Massari F, Ciccarese C, Modena A, Maines F, Segala D, Luchini C, Marcolini L, Cavicchioli F, Cavalleri S, Bria E, Brunelli M, Martignoni G, Artibani W, Tortora G. Massari F, et al. Among authors: ciccarese c. Histol Histopathol. 2014 Oct;29(10):1295-303. doi: 10.14670/HH-29.1295. Epub 2014 Mar 7. Histol Histopathol. 2014. PMID: 24604416
Quantitative score modulation of HSP90 and HSP27 in clear cell renal cell carcinoma.
Massari F, Ciccarese C, Porcaro AB, Ferrero S, Gazzano G, Artibani W, Modena A, Bria E, Sava T, Caliò A, Novara G, Ficarra V, Chilosi M, Martignoni G, Bosari S, Cheng L, Tortora G, Brunelli M. Massari F, et al. Among authors: ciccarese c. Pathology. 2014 Oct;46(6):523-6. doi: 10.1097/PAT.0000000000000150. Pathology. 2014. PMID: 25188333
Methods to identify molecular expression of mTOR pathway: a rationale approach to stratify patients affected by clear cell renal cell carcinoma for more likely response to mTOR inhibitors.
Fiorini C, Massari F, Pedron S, Sanavio S, Ciccarese C, Porcaro AB, Artibani W, Bertoldo F, Zampini C, Sava T, Ficial M, Caliò A, Chilosi M, D'Amuri A, Sanguedolce F, Tortora G, Scarpa A, Delahunt B, Porta C, Martignoni G, Brunelli M. Fiorini C, et al. Among authors: ciccarese c. Am J Cancer Res. 2014 Nov 19;4(6):907-15. eCollection 2014. Am J Cancer Res. 2014. PMID: 25520878 Free PMC article.
PD-1 blockade therapy in renal cell carcinoma: current studies and future promises.
Massari F, Santoni M, Ciccarese C, Santini D, Alfieri S, Martignoni G, Brunelli M, Piva F, Berardi R, Montironi R, Porta C, Cascinu S, Tortora G. Massari F, et al. Among authors: ciccarese c. Cancer Treat Rev. 2015 Feb;41(2):114-21. doi: 10.1016/j.ctrv.2014.12.013. Epub 2015 Jan 6. Cancer Treat Rev. 2015. PMID: 25586601 Review.
The route to personalized medicine in bladder cancer: where do we stand?
Massari F, Ciccarese C, Santoni M, Brunelli M, Conti A, Modena A, Montironi R, Santini D, Cheng L, Martignoni G, Cascinu S, Tortora G. Massari F, et al. Among authors: ciccarese c. Target Oncol. 2015 Sep;10(3):325-36. doi: 10.1007/s11523-015-0357-x. Epub 2015 Jan 30. Target Oncol. 2015. PMID: 25634607 Review.
129 results